Unresectable Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Trastuzumab deruxtecan (DB14962)

IndicationStatusPhase
DBCOND0110416 (Unresectable Malignant Solid Neoplasm)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04294628
Testing the Biological Effects of DS-8201a on Patients With Advanced CancerTreatment